Table 1 Selected clinical and demographic parameters of the study population.

From: Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death

Characteristic

Milda

Moderately-Severeb

P value

No. of subjects

18

19

 

Male, n (%)

13 (72.2)

15 (78.9)

 

Female, n (%)

5 (27.8)

4 (21.1)

 

Age in yrs, median (IQRc)

60.6 (52.0 − 64.0)

59.9 (55.1 − 66.2)

0.23

BMI, median (IQR)

26.3 (25.0 − 28.4) [n = 8]

28.5 (26.4 − 37.9) [n = 10]

0.20

AST Liver Enzyme, median (IQR)

31.5 (23.8 − 47.5) [n = 10]

52.5 (36.8 − 75.8) [n = 10]

0.19

ALT Liver Enzyme, median (IQR)

36.0 (29.3 − 42.0)

40.0 (30.0 − 58.0)

0.70

Lymphocytes, median (IQR)

1.47 (1.17 − 1.94)

0.81 (0.66 − 1.23)

0.002

Neutrophils, median (IQR)

4.13 (2.34 − 5.59)

5.34 (4.46 − 7.52)

0.019

CRP, median (IQR)

2.27 (1.08 − 4.37)

13.35 (8.22 − 24.0)

0.0003

Pct, median (IQR)

0.09 (0.05 − 0.14)

0.33 (0.15 − 1.14)

0.032

Ferritin, median (IQR)

333 (223 − 407)

932 (568 − 1635)

0.014

Fibrinogen, median (IQR)

439 (405 − 646)

625 (506 − 737)

0.015

  1. CRP C reactive protein; AST aspartate aminotransferase; ALT Alanine aminotransferase.
  2. aNasal cannula or VentMask, bCPAP, Continuous positive air pressure, cIQR, interquartile range.
Back to article page